Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Breast Neoplasms × Behavior Therapy × Clear all

Phase

Status

Completed 6 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vulvar Neoplasms 1 Vaginal Neoplasms 1 Triple Negative Breast Neoplasms 1 Ovarian Neoplasms 1 Genital Neoplasms, Female 1 Endometrial Neoplasms 1 Breast Neoplasms 1

Interventions

Paclitaxel 20 Trastuzumab 17 Docetaxel 13 Cyclophosphamide 13 Capecitabine 10 Letrozole 9 Doxorubicin 9 exemestane 8 Radiotherapy 8 Fulvestrant 8 Lapatinib 7 Carboplatin 7 pembrolizumab 6 Goserelin 6 Anastrozole 6 palbociclib 5 eribulin 5 Therapeutics 5 Neoadjuvant Therapy 5 Chemotherapy, Adjuvant 5 Bevacizumab 5 Aromatase Inhibitors 5 tucatinib 4 abemaciclib 4 Vinorelbine 4 Taxes 4 Mastectomy, Segmental 4 Magnetic Resonance Spectroscopy 4 Exercise 4 Epirubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01738685 2016-11-15

Relief

University of Pittsburgh

Phase NA Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡